Dr. Bodour Salhia, a TGen cancer researcher, traveled to Egypt in October as a U.S. delegate with the Susan G. Komen for the Cure organization in a highly successful effort to raise awareness about breast cancer.
On Oct. 23, the eve of Cairo’s first Komen race, pink spotlights bathed The Great Pyramid of Giza.
The next day, Dr. Salhia joined nearly 10,
Time is money. Money is time. These two common phrases carry considerable consequence for non-profits. Ray Thurston’s contributions to TGen provide added value in both contexts.
Thurston, the founder of Sonic Air, is fascinated with quickly getting from one place to another, whether that means people, packages or ideas.
“It became our culture of consta
A decade ago, doctors told Troy Richards that he might have only 6-8 months to live. During a scan of a hernia, doctors found an 8-inch-long tumor – about the size of a football – growing atop his left kidney.
The news came as an incredible shock to Richards, an energetic Tucson businessman who at the time owned multiple Wendy’s restaurant franchises. Espec
A Collaborative Effort
Dr. Meurice will lead the Southwest Comprehensive Center for Drug Discovery and Development’s computational chemistry efforts, while Co-PI’s Dr. Christopher Hulme, Associate Professor at the UA College of Pharmacy will lead the center’s medicinal chemistry efforts and TGen Sr. Investigator Dr. Spyro Mousses, will lead the high throug
For more than three decades, the “Sanger” method dominated genetic sequencing – the spelling out of the A’s, G’s, C’s and T’s in a molecule of DNA in search of the variations that cause human disease.
Named for Dr. Frederick Sanger, an English biochemist and two-time Nobel laureate in chemistry, the Sanger method provided science in the late 1970s an advanc
TGen and the University of Pennsylvania (Penn) have received a three-year, $18 million grant from Stand Up to Cancer (SU2C) to research pancreatic cancer.
Dr. Daniel Von Hoff, TGen’s Physician-In-Chief, and Dr. Craig B. Thompson, Director of the Abramson Cancer Center at Penn, are co-leaders of SU2C’s pancreatic cancer “Dream Team,’’ which will investigate
TGen and UC Berkeley scientists use ‘pooled’ method to discover gene associated with non-Hodgkin lymphoma
Follicular lymphoma accounts for as much as 30 percent of all non-Hodgkin lymphoma (NHL), a cancer of the lymphatic system involving the blood, bone marrow and lymph nodes.
It was a little outside of his scientific comfort zone, but TGe
Drug used in stroke patients may reduce risk of Alzheimer's disease; improve learning and memory
A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a recent study by investigators at TGen, Arizona State University and the Arizona Alzheimer's Consortium.
The Translational Genomics Research Institute (TGen) and the Van Andel Research Institute (VARI) will forge a strategic alliance that will enable both to maximize their worldwide contributions to science and health. The non-profit research institutes jointly announced...
Doctor thrives in dual role as TGen cancer researcher and medical school faculty
In her dual role as a TGen investigator and a medical school instructor, it is not enough for Dr. Suwon "Sue" Kim to simply teach.
She wants her doctors-in-training to go beyond memorizing texts and jump into research riddles.
"I like solving puzzles," said Kim, who